Shattuck Labs (STTK) Non-Current Deffered Revenue (2019 - 2021)
Shattuck Labs' (STTK) quarterly Non-Current Deffered Revenue came in at $2.2 million in Q4 2021, down 89.61% year-on-year from $21.3 million in Q4 2020, and down 91.89% on a QoQ basis from $27.3 million in Q3 2021.
Shattuck Labs (STTK) Non-Current Deffered Revenue (2019 - 2021) Analysis & Trends
Shattuck Labs (STTK) has 3 years of Non-Current Deffered Revenue data on file, last reported at $2.2 million in Q4 2021.
- On a quarterly basis, Non-Current Deffered Revenue fell 89.61% year-over-year to $2.2 million in Q4 2021; TTM through Dec 2021 was $2.2 million, a 89.61% decrease from a year earlier, with the FY2021 full-year figure at $2.2 million, down 89.61% from the prior year.
- Non-Current Deffered Revenue for Q4 2021 stood at $2.2 million, down from $27.3 million in the prior quarter.
- Over the last five years, Non-Current Deffered Revenue for STTK reached as high as $29.2 million in Q2 2021 and fell as low as $898000.0 in Q4 2019.
- Historically, Non-Current Deffered Revenue has averaged $12.0 million across 3 years, with a median of $2.2 million in 2021.
- On a YoY basis, Non-Current Deffered Revenue climbed as much as 2894.18% in 2021 and fell as far as 89.61% in 2021.
- Year by year, Non-Current Deffered Revenue stood at $898000.0 in 2019, then surged by 2272.61% to $21.3 million in 2020, then tumbled by 89.61% to $2.2 million in 2021.
- Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $2.2 million in Q4 2021, $27.3 million in Q3 2021, and $29.2 million in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 225.10 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Shattuck Labs | 831.66 Mn | 831.66 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 2.21 Mn |
| Sep 30, 2021 | 27.28 Mn |
| Jun 30, 2021 | 29.22 Mn |
| Mar 31, 2021 | 2.20 Mn |
| Dec 31, 2020 | 21.31 Mn |
| Sep 30, 2020 | 911,000.00 |
| Dec 31, 2019 | 898,000.00 |